Established in 2001, Ibnsina Pharma distributes pharmaceutical products from over 350 Egyptian and multinational pharmaceutical companies to more than 50,000 customers, including pharmacies, hospitals, retail outlets, and wholesalers, using a fleet of around 830 vehicles and a team of more than 6,000 people. In 2023, it recorded a 52.5% increase in net sales compared to 2022, reaching $708 million, and a 24.8% increase in net profits, reaching $4 million.